SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: Mammon who wrote (563)2/3/2002 10:18:14 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 1169
 
VRTX was very high on list in ‘99/'00, after Novartis deal. However, and as many times before, perspective and hope were one things and reality another one. They have few serious problems and market turned more cautious. Before anyone can expect change they need to show that they can deliver new drugs without very frequent blowout.

Hope things will change for better, soon.

Miljenko


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News